- Home
- Companies
- equatorial guinea
- clinical development
Refine by
Industries served
- Medical / Health Care
- Chemical & Pharmaceuticals
- Monitoring and Testing
- Environmental
- Manufacturing, Other
- Agriculture
- Health and Safety
- Banking & Finance / Insurance / Legal
- Defense
- Aerospace & Air Transport
- Retail
- Waste and Recycling
- Air and Climate
- Soil and Groundwater
- University / Academia / Research
- Food and Beverage
- Energy
- Construction & Construction Materials
Clinical Development Suppliers Serving Equatorial Guinea
285 companies found
based inBeirut, LEBANON
NUMED is a Lebanese and Middle East based company that provides and manufactures medical and nutrition clinical equipment along with general and customized educational tools adapted for the local and international populations. NUMED can offer ...
based inSint-Denijs Westrem, BELGIUM
We are a commercial stage medical device company developing the alfapump® platform for the treatment of fluid overload in liver disease, malignant ascites and heart failure where diuretics are no longer effective. The alfapump®, is a fully ...
based inStockholm, SWEDEN
As a leading innovator of precision radiation therapy solutions, Elekta is committed to ensuring that every patient has access to the best cancer care possible. At Elekta, our outcome-driven and cost-efficient solutions provide lasting clinical ...
based inWendelsheim, GERMANY
AESKU.GROUP, based in Wendelsheim, Germany, is a research-focused supplier of innovative and efficient products and services for the early detection, diagnosis and prognosis of autoimmune diseases. AESKU.DIAGNOSTICS is a leading manufacturer of ...
based inSaint Louis, MISSOURI (USA)
Sequoia Vaccines is a clinical stage pharmaceutical company discovering and developing new vaccines preventing bacterial infections and medicines treating cancers and bacterial infections. Sequoia’s lead clinical candidate is a vaccine for the ...
Sequoia is developing an anticancer compound (SQ1274) for use against solid tumors including ovarian and lung ...
based inParis, FRANCE
Enterome is pioneering the discovery and development of novel pharmaceuticals based on its unrivalled understanding of the interaction between the gut microbiome and the immune system – the Microbiome-Immunoinflammation Axis. Enterome is using this ...
based inNew York, NEW YORK (USA)
Medidata is leading the digital transformation of life sciences, creating hope for millions of patients. Medidata helps generate the evidence and insights to help pharmaceutical, biotech, medical device and diagnostics companies, and academic ...
Medidata AI Integrated Evidence connects historical data from more than 23,000 cross-sponsor clinical trials and 7 million patient volunteers with real world data to deliver powerful insights and the necessary evidence ...
based inBeijing, CHINA
Chemclin Diagnostics Co., Ltd (hereinafter it was referred to as Chemclin Diagnostics), founded in 2007, is one of the pioneers in developing clinical immunoassays and systems in China. Chemclin Diagnostics is specialized in the research and ...
based inLake Forest, CALIFORNIA (USA)
eVent Medical has maintained continuous growth for over a decade, bringing yet more veterans of the ventilator industry to the team while maintaining our sole focus on mechanical ventilation. Mechanical ventilation manufacturing began in California ...
based inChaska,, MINNESOTA (USA)
Lifecore Biomedical is a full-service contract development and manufacturing organization (CDMO) that partners with pharmaceutical and biotech companies to develop and deliver vital and complex injectable therapies. For more than 30 years, we have ...
Drug product formulation development starts with an understanding of the drug substance. Our experts work with you to define and understand the anticipated use, desired performance criteria, characteristics of the drug product, distribution, ...
based inSan Diego, CALIFORNIA (USA)
Vala Sciences helps researchers achieve an unrivaled in vitro understanding of how human cells respond to drug compounds. Vala is committed to providing expert services to pharmaceutical developers and researchers to help overcome the persistent ...
ValaDATE (Deep Analytics for Toxicity & Efficacy) AI is Vala’s development stage artificial intelligence platform that we believe will further automate and accelerate how we process the vast data produced by the Vala ...
based inNeedham, MASSACHUSETTS (USA)
Invicro is an integral part of the REALM IDx, Inc. group, which aims to accelerate personalized medicine, discover novel therapeutic targets and develop innovative therapeutic technologies for unmet medical needs. As a global research partner to the ...
Radiopharmaceutical therapies represent an effective way to treat solid cancers by using tumor targeting small molecules, peptides or biologics to deliver a cytotoxic payload that induces DNA damage in tumor cells, while limiting damage to normal ...
based inOslo, NORWAY
Bio-Me is Setting the Standard for Routine Microbiome Analysis. Gut microbiome research has become essential to almost every medical research field. Next-generation sequencing (NGS) technologies have been crucial in enabling a breakthrough in our ...
PMP™ technology – Bridging the gap between clinical research and clinical practice by translating knowledge into actionable information. Microbiome Analysis Services for Pharma and Drug ...
based inBoston, MASSACHUSETTS (USA)
At PathAI, we’re dedicated to improving patient outcomes with reliable AI-Powered technology and meaningful collaboration with biopharma, laboratories, and clinicians — aiming to provide patients with access to accurate diagnoses and effective ...
AISightTM is a web-based digital pathology slide viewing platform that enables the management and analysis of whole slide ...
based inDreieich, GERMANY
Biotest - innovation in haematology, clinical immunology and intensive care medicine. Biotest is a specialist in innovative haematology, clinical immunology and intensive care medicine. Biotest develops, manufactures and markets plasma proteins and ...
Trimodulin is an innovative polyvalent antibody composition, purified from human plasma. In comparison to standard IgG preparations (IVIG), trimodulin contains relevant amounts of IgM and IgA in addition to ...
based inCambridge, MASSACHUSETTS (USA)
Seres Therapeutics is a late-clinical stage biotechnology company with a strong development pipeline and rigorous scientific underpinning, working to revolutionize treatment of a wide range of diseases by modulating the function of the human ...
SER-155 is an investigational, oral, rationally designed, fermented microbiome therapeutic designed to reduce the incidence of gastrointestinal infections, bacteremia, and graft versus host disease (GvHD) in immunocompromised patients, including ...
based inCambridge, UNITED KINGDOM
We’re driven by the shared purpose of breaking new ground in the discovery of new treatments for rare diseases. Healx is a mission-driven technology company pioneering the next wave of drug discovery in order to bring novel, effective treatments to ...
Our Rare Treatment Accelerator helps academic, patient, and industry groups advance their rare disease drug redevelopment projects. By combining our team, expertise and financial resources with your research and insights, we can get treatments to ...
based inZug, SWITZERLAND
SHL Medical is a world-leading solutions provider in the design, development, and manufacturing of advanced delivery devices such as autoinjectors, pen injectors, and innovative specialty delivery systems for large-volume and high-viscosity ...
The establishment of the Molly platform signifies SHL’s commitment to further addressing the varying needs of our customers and their patients. Introduced in 2010, Molly is SHL’s first preconfigured autoinjector designed to help ...
based inBundoora, AUSTRALIA
AdAlta is an innovative, clinical stage biotech company developing a unique range of new drug treatments. AdAlta has pioneered a technology that mimics the shape and stability of a crucial antigen-binding domain, discovered initially in sharks and ...
AdAlta is utilising the power of the i-body technology platform to develop a growing pipeline of i-bodies to treat a range of conditions, with an initial focus on treating fibrotic diseases. AdAlta identified an i-body that binds to the drug target, ...
based inLondon, UNITED KINGDOM
Founded in 2015, the original idea behind Airfinity was to systematically capture and structure the new science disseminated at conferences, a highly fragmented dataset. However, through working with medical associations and pharma companies, ...
Monitor, evaluate and anticipate the use of real world data and evidence around the globe, as well as its impact on the regulatory landscape. Real-world data (RWD) and real-world evidence (RWE) is playing an increasingly important role in how ...
